Klotho Neurosciences, Inc.
KLTO
$0.1817
$0.016710.12%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.85M | 2.87M | 395.60K | 672.00K | 110.70K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.85M | 2.87M | 395.60K | 672.00K | 110.70K |
Operating Income | -1.85M | -2.87M | -395.60K | -672.00K | -110.70K |
Income Before Tax | -2.07M | -2.96M | -451.60K | -672.00K | -126.50K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -2.07M | -2.96M | -451.60K | -672.00K | -126.50K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -2.07M | -2.96M | -451.60K | -672.00K | -126.50K |
EBIT | -1.85M | -2.87M | -395.60K | -672.00K | -110.70K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.08 | -0.18 | -0.03 | 0.00 | -0.01 |
Normalized Basic EPS | -0.05 | -0.11 | -0.02 | 0.00 | -0.01 |
EPS Diluted | -0.08 | -0.18 | -0.03 | 0.00 | -0.01 |
Normalized Diluted EPS | -0.05 | -0.11 | -0.02 | 0.00 | -0.01 |
Average Basic Shares Outstanding | 27.22M | 16.69M | 15.68M | 1.04B | 15.13M |
Average Diluted Shares Outstanding | 27.22M | 16.69M | 15.68M | 1.04B | 15.13M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |